Lone Hoffmann (@lone_hoffmann) profile picture
Arhus, Denmark
Joined August 2021
Photo by Lone Hoffmann (@lone_hoffmann)Photo by Lone Hoffmann (@lone_hoffmann)Photo by Lone Hoffmann (@lone_hoffmann)Photo by Lone Hoffmann (@lone_hoffmann)Photo by Lone Hoffmann (@lone_hoffmann)Photo by Lone Hoffmann (@lone_hoffmann)Photo by Lone Hoffmann (@lone_hoffmann)Photo by Lone Hoffmann (@lone_hoffmann)Photo by Lone Hoffmann (@lone_hoffmann)Photo by Lone Hoffmann (@lone_hoffmann)
Lone Hoffmann retweeted
🌟 Join Our HYBRID Course on IMRT and VMAT: Best practices and new trends! 🌟 ⏰ Don’t miss out and apply before the early deadline live course: 14 August 2024 and for the online course: 11 September 2024 👉Read more information and register : bit.ly/3W3eAZt #radonc
3
7
708
The RTQA group visited USZ and PSI (Switzerland). Through the exchange of treatment experiences, these visits are of great value to the PROTECT study and the participating sites. All with the common goal of improving the treatment of esophageal cancer. (protecttrial.eu)
1
1
8
323
First of the yearly RTQA meetings in the PROTECT trial. Great success with a lot of fantastic contributions and discussions. More than 40 participants. Thank you for joining. Looking forward to continued collaboration.
1
1
11
515
⭐ Rest up, recharge, and get ready for more tomorrow. 💙 See you bright and early for the final day of #FRPT2023
2
4
438
💙 Thank you for being a part of today's success—can't wait to continue sharing knowledge with you tomorrow. Until then, goodnight and see you soon! #FRPT2023
2
1
6
828
First 🇨🇭 oesophageal cancer patient enrolled into randomized PROTECT trial, comparing neoadjuvant Photon or Proton radiochemotherapy 👉 Strong collaboration between @psich_de and @Unispital_USZ @RadOncUSZ @CCCZ_USZ psi.ch/de/media/forschung/pr…
9
1
52
2,509
Sådan💪- stor ros til Nationalt Forskningscenter for Stråleterapi for "Fremragende forskning, som bidrager til bedre strålebehandling af kræftpatienter i hele Danmark". Centret er blevet til med støtte fra #Knækcancer #dkforsk #sundpol cancer.dk/nyheder/stor-ros-t…
6
22
1,570
Absolutely fantastic @DCCC_RT workshop on dose mapping/accumulation. Critical discussions of what can be done now with the (limited) tools we have available and what we would need to get this in daily practice for both #reirradiation and #ART. Tak @lone_hoffmann & @IsakWahlstedt – at Middelfart, Danmark
2
2
10
540
Lone Hoffmann retweeted
The IMRT/VMAT course will focus on the latest developments in the area including the technical aspects of treatment preparation & delivery, dose calculation, QA process, clinical outcomes, site-specific issues, normal tissue tolerance, emerging indications https://nitter.cf/t.co/6wlMfuvBlE
6
9
1,507
Stort tillykke med tiltrædelsen som professor på @SUND_SDU @TineSchytte 🎉 Flot gennemgang af din forskning om #strålebehandling af patienter med #lungekræft og på #MRlinac 👏🏼 Stærkt program med præsentationer fra @craneMSKCC og @OlfredHansen 💪🏼 @OUHhospital – at Odense, Danmark
1
2
20
1,696
Lone Hoffmann retweeted
Clinical professor Tine Schytte Inaugural seminar :-) Congratulations to Odense university 🌹
1
14
400
Lone Hoffmann retweeted
Done Narlal2 clinicaltrials.gov/ct2/show/… trail 350 patients included in #Denmark and #Norway #DOLG #NSCLC #radonc 💃🏻💃🏻💃🏻Thank you all
1
4
261
First of many site visits completed. As a part of the PROTECT study all RT sites goes through an ambitions review program. AUH/DCPT had the pleasure of being quality assured by staff from @OncoRay_Press & @MAASTROclinic. Read more about WP3 QA at protecttrial.eu/currently/wo…
1
3
10
623
DONE! The NARLAL2 trial has just randomised patient #350! That's 350 NSCLC patients treated with either 66Gy or PET-driven inhomogeneous dose escalation. Absolutely amazing effort by the entire team. Now we wait a year for the primary endpoint 😊 #radonc clinicaltrials.gov/ct2/show/…
5
5
1
41
5,966
Lone Hoffmann retweeted
Follow the course for latest develpmnts in #IMRT/#VMAT: technical aspects of treatment preparation & delivery, dose calculation, QA process, clinical outcomes, site-specific issues, normal tissue tolerance, emerging indications etc Early deadline: 8 March https://nitter.cf/t.co/6wlMfuvBlE
2
1
5
1,359
Lone Hoffmann retweeted
Many, many thanks to all the participants and to my brilliant co-chairs @elivaos @ChuckMayoPhD and Andy Jackson #ESTROphyswork2022
2
2
1
22
Lone Hoffmann retweeted
We continued today with data reporting, outcome modelling, and registry studies in re-irradiation. Such a joy! (Even if one of the conclusions were “we’re never going to get a meta analysis out of the re-irradiation literature” 😕) #medphys #radonc #ESTROphyswork2022
1
2
9
We start @ESTRO_RT physics workshop with @CatharineHClark telling us about the history of the workshop. I'm so excited to not only participating but co-chairing with @cancerphysicist, @ChuckMayoPhD and Andy Jackson the reirradiation theme in this thought-inspiring event!!
2
5
25
Prof Ben Heijmen giving a fantastic keynote lecture at the 2022 @ESTRO_RT physics workshop, linking music recommender systems to decision support tools in #radonc. Can we avoid be biased by automatic recommendations? #medphys
2
1
1
29
Lone Hoffmann retweeted
What happens when 35 physicists (& colleagues) get together to discuss re-irradiation? Something exciting! At least based on today's virtual introduction to the 2022 @ESTRO_RT reRT physics workshop. Looking forward to meeting these excellent people in person in October #medphys
5
3
60